Educational information, not medical advice — ask your doctor or midwife.
Track Khamira Abresham (Unani) with reminders and record whether it helped, in the app.
Khamira Abresham is a classical Unani compound formulation that has been used across Persia, South Asia, and the broader Islamic medical tradition for over 800 years. It is an electuary — a thick, honey-based medicinal paste — whose star ingredient is purified silk (Abresham), combined with an array of cardiac tonics, aromatic herbs, and mineral ingredients. Different variant formulations exist, including Sada (plain), Hakim Arshad Wala (with additional gems and amber), and Jadwar (with aconitum), each tailored to slightly different indications.
In Unani medicine, Khamira Abresham is classified as a Mufarreh (cardiac tonic and mood-lifter) and a Muqawwi-e-Qalb (heart strengthener). The combination of silk proteins, saffron, sandalwood, and rose is thought to gently calm an overactive heart, cool excess internal heat (Hararat), and nourish the vital spirit (Rooh) associated with the heart and brain. Modern pharmacological research on its individual ingredients suggests mechanisms including antioxidant activity, mild adaptogenic effects, anti-inflammatory action, and positive influence on stress hormones — though the compound formula itself has limited modern clinical trial data.
Khamira Abresham is traditionally dispensed as a thick paste or soft electuary, taken by the spoonful. Some modern Unani pharmacies prepare it as granules or semi-solid sachets. It is always taken orally and is typically made to traditional formulations registered with the Ministry of AYUSH in India and national pharmacopeias of Pakistan and Bangladesh.
The formula traces back to classical Unani texts including the Qarabadeen-e-Qadeem and the works of Ibn Sina (Avicenna) and later Hakim Ajmal Khan. It became a cornerstone preparation of the Indo-Persian Unani tradition, especially for treating heart weakness (Dua'f-e-Qalb), palpitations, anxiety, and general debility. The preparation remains in active clinical use across South Asia and in Unani hospitals in India, Pakistan, and Bangladesh.
Evidence grades and traditional-use labels are explained in our methodology. Nothing here is medical advice.
Reviewed by the HealisticMD editorial team How we grade evidence →
The published evidence for Khamira Abresham (Unani) is weak or absent. That usually means no controlled trial has tested it, not that a trial found it ineffective — the two are different, and we grade only what has been published.
What it is typically used for, usual dose, cautions, and the study behind it where real trial data exists.
One email with the summary. We'll also send a short weekly evidence update — unsubscribe any time.